ALung Technologies recently announced the initiation of patient enrollment in its VENT-AVOID trails with the Minneapolis Heart Institute Foundation. The trial is pivotal in validating the safety and efficacy of the Hemolung Respiratory Assist System for COPD patients who require ventilatory support.
Recent Posts
Enterprises portfolio company, Curavi Health, acquires TripleCare
Since its inception in 2016, Curavi Health has focused on addressing the care gaps in …
Read More →
What is the secret sauce of a health care startup?
Last month, Fast Company published an article looking at trends in the digital health startup space and comparing the traits of consumer based tech companies to health care startups.
Read More →